PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
-5.07%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$4.94B
AUM Growth
+$4.94B
(-4.9%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
23%
Holding
316
New
46
Increased
110
Reduced
87
Closed
39
Top Buys
| 1 |
UnitedHealth
UNH
|
$47M |
| 2 |
AGN
Allergan plc
AGN
|
$46.5M |
| 3 |
Eli Lilly
LLY
|
$39.8M |
| 4 |
Bank of America
BAC
|
$31.1M |
| 5 |
Pfizer
PFE
|
$30.6M |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
$55.2M |
| 2 |
Thermo Fisher Scientific
TMO
|
$42.2M |
| 3 |
Zimmer Biomet
ZBH
|
$35.5M |
| 4 |
Cooper Companies
COO
|
$35.5M |
| 5 |
Roper Technologies
ROP
|
$31.5M |
Sector Composition
| 1 | Healthcare | 25.89% |
| 2 | Technology | 24% |
| 3 | Financials | 21.01% |
| 4 | Communication Services | 9.92% |
| 5 | Consumer Discretionary | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fidelity National Information Services
FIS
$35.6B
| $46.2M | 0.93% |
688,594
-131,841
| -16% | -$8.84M |
|
|
VR
27
DELISTED
Validus Hold Ltd
VR
| $45.1M | 0.91% |
1,000,123
+528,175
| +112% | +$23.8M |
|
28
Waste Connections
WCN
$46.5B
| $44.8M | 0.91% |
921,397
+25,444
| +3% | +$1.24M |
|
29
Amdocs
DOX
$9.31B
| $44M | 0.89% |
773,802
-113,649
| -13% | -$6.46M |
|
30
Wells Fargo
WFC
$258B
| $43.5M | 0.88% |
847,820
-5,445
| -0.6% | -$280K |
|
31
Aecom
ACM
$16.4B
| $43.5M | 0.88% |
1,580,095
+87,380
| +6% | +$2.4M |
|
32
Icon
ICLR
$14B
| $38.4M | 0.78% |
541,597
+84,067
| +18% | +$5.97M |
|
33
Oracle
ORCL
$628B
| $37.8M | 0.76% |
1,045,423
-351,429
| -25% | -$12.7M |
|
34
Cisco
CSCO
$268B
| $37.7M | 0.76% |
1,436,467
-52,688
| -4% | -$1.38M |
|
35
PNC Financial Services
PNC
$80.7B
| $37M | 0.75% |
415,018
-3,679
| -0.9% | -$328K |
|
|
CELG
36
DELISTED
Celgene Corp
CELG
| $36.5M | 0.74% |
337,724
+30,716
| +10% | +$3.32M |
|
37
Amazon
AMZN
$2.41T
| $36.5M | 0.74% |
71,387
-26,486
| -27% | -$13.6M |
|
38
Stryker
SYK
$149B
| $36.3M | 0.73% |
385,547
-17,426
| -4% | -$1.64M |
|
39
Marsh & McLennan
MMC
$101B
| $36M | 0.73% |
690,000
+34,000
| +5% | +$1.78M |
|
40
Lazard
LAZ
$5.19B
| $35.9M | 0.73% |
828,027
-129,555
| -14% | -$5.61M |
|
|
RVNC
41
DELISTED
Revance Therapeutics, Inc.
RVNC
| $35.2M | 0.71% |
1,184,530
+54,121
| +5% | +$1.61M |
|
|
BCR
42
DELISTED
CR Bard Inc.
BCR
| $34.7M | 0.7% |
186,375
+126,375
| +211% | +$23.5M |
|
|
43
Thermo Fisher Scientific
TMO
$183B
| $33.3M | 0.67% |
272,168
-345,223
| -56% | -$42.2M |
|
|
WBA
44
DELISTED
Walgreens Boots Alliance
WBA
| $32.1M | 0.65% |
385,768
-24,232
| -6% | -$2.01M |
|
45
Comcast
CMCSA
$125B
| $31.3M | 0.63% |
549,638
-290,999
| -35% | -$16.6M |
|
|
46
Bank of America
BAC
$371B
| $31.1M | 0.63% |
+1,996,657
| New | +$31.1M |
|
|
AET
47
DELISTED
Aetna Inc
AET
| $28.9M | 0.59% |
264,479
-137,442
| -34% | -$15M |
|
48
Regeneron Pharmaceuticals
REGN
$59.8B
| $28.9M | 0.58% |
62,077
+56,084
| +936% | +$26.1M |
|
49
Ultragenyx Pharmaceutical
RARE
$3.04B
| $28.5M | 0.58% |
295,879
+33,818
| +13% | +$3.26M |
|
|
ALXN
50
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $28.3M | 0.57% |
180,855
-444
| -0.2% | -$69.4K |
|